Fox Chase Cancer Center Receives $1.5 Million Challenge Grant From The Kresge Foundation
PHILADELPHIA (April 14, 1998) -- The Kresge Foundation of Troy, Michigan, has awarded Fox Chase Cancer Center of Philadelphia a grant of $1,500,000 toward construction of the Center's new Cancer Prevention Pavilion, for which the Center will break ground May 14. In announcing the grant, Foundation president John E. Marshall III congratulated the Center on receiving one of the largest 1998 challenge grants Kresge has made to date.
The Prevention Pavilion to be built on the Fox Chase campus is the keystone and major building project of the Center's $38 million Campaign for Cancer Prevention. The Kresge challenge grant requires Fox Chase to raise more than $5 million in new gifts and grants by September 1999 to complete the funding of the Prevention Pavilion before the Foundation releases its funds.
More than $16 million has been raised for the building so far. The overall campaign total to date, including funds for research programs and endowments, exceeds $21 million.
The new laboratories will bring together leading scientists and researchers in different fields such as human genetics, molecular epidemiology, behavioral research and others-all working under one roof and dedicated to cancer prevention.
The Prevention Pavilion will also include clinical facilities to provide services for people at high risk of specific cancers. Programs already in place include the Margaret Dyson Family-Risk Assessment Program for women with a family history of breast or ovarian cancer; the Gastrointestinal Tumor Risk-Assessment Program for men and women at risk of colon, rectal, pancreatic or stomach cancer; and the Prostate Cancer Risk-Assessment Program.
Already a leader in prevention research, the Center is focusing on the next wave of progress in science and medicine, according to Fox Chase president Dr. Robert C. Young.
"Our challenge now is to develop a new approach for the next century-to learn how to prevent cancer before it ever strikes," Young said.
One of Young's special advisers is Fox Chase Distinguished Scientist Dr. Baruch S. Blumberg, a Nobel laureate and former master of Balliol College, Oxford University. He discovered the hepatitis B virus 30 years ago and went on to develop the first vaccine against it. This was the first vaccine capable of preventing a human cancer, primary cancer of the liver, a major cancer worldwide that is associated with chronic hepatitis infection in more than 80 percent of cases.
A featured guest speaker at the May 14 ground-breaking ceremony for the Prevention Pavilion will be actor and cancer survivor Robert Urich. Other invited guests from the Delaware Valley, New York and Washington, D.C., include Carolyn R. Aldig, founder of the Washington-based Cancer Research Foundation of America and recently appointed president of the National Coalition for Cancer Research, and Dr. Harold P. Freeman, director of surgery at Harlem Hospital and new chairman of the President's Cancer Panel. Both serve on the Fox Chase board of directors.
Kresge is one of the few major foundations in the United States concentrating on bricks-and-mortar campaigns, providing construction funds to universities, hospitals, research centers and other institutions. Fox Chase has received four previous capital challenge grants from Kresge. The most recent, in 1991, was for $750,000 toward construction of the West Building, housing a centralized outpatient facility and laboratories. The Center also received a Science Initiative grant from Kresge in 1994.
Past recipients of a $1.5 million Kresge challenge grant include the American Museum of Natural History and Memorial Sloan-Kettering Cancer Center in New York City and Northwestern Memorial Hospital in Chicago.
Fox Chase Cancer Center is one of 32 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research, prevention, detection and treatment of cancer and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).